中华核医学杂志
中華覈醫學雜誌
중화핵의학잡지
CHINESE JOURNAL OF NUCLEAR MEDICINE
2010年
1期
10-14
,共5页
蔡莉%张川%李彦生%李大成%邢喜玲%高硕
蔡莉%張川%李彥生%李大成%邢喜玲%高碩
채리%장천%리언생%리대성%형희령%고석
神经胶质瘤%体层摄影术,发射型计算机%脱氧葡萄糖%缺氧诱导因子1,α亚基%微血管密度
神經膠質瘤%體層攝影術,髮射型計算機%脫氧葡萄糖%缺氧誘導因子1,α亞基%微血管密度
신경효질류%체층섭영술,발사형계산궤%탈양포도당%결양유도인자1,α아기%미혈관밀도
Glioma%Tomography,emission-computed%Deoxyglucose%Hypexia-inducible factor 1,alpha subunit%Microvessel density
目的 探讨人脑胶质瘤~(18)F-脱氧葡萄糖(FDG)摄取水平与乏氧诱导因子-1α(HIF-1α)表达及微血管密度(MVD)之间的相关性.方法 对41例脑胶质瘤(其中高级别肿瘤23例,低级别肿瘤18例)患者术前行~(18)F-FDG PET检查,计算肿瘤与对侧正常脑白质的最大标准摄取值(SUV_(max))比值(T/WM).肿瘤标本采用免疫组织化学染色,观察HIF-1α表达及定量研究肿瘤MVD,评价T/WM与HIF-1α表达及MVD的相关性.用SPSS 11.5软件进行t检验、单因素方差分析及Spearman相关分析、Wilcoxon秩和检验.结果 (1)高、低级别肿瘤的T/WM、HIF-1α阳性表达率及MVD分别为3.39 ±1.43,95.7%,44.13±16.1和1.46±0.55,55.6%,18.83±7.07,2组间T/WM、HIF-1α表达及MVD差异均有统计学意义(t=-5.921,z=-3.938,t=-6.745,P均<0.05).(2)所有病例中HIF-1α强表达8例,中度表达9例,弱表达15例,阴性表达9例.T/WM及MVD均随HIF1α表达水平升高而增加,组间差异有统计学意义(F=7.41,P<0.05).(3)Spearman相关分析表明,41例胶质瘤的T/WM与MVD呈明显正相关(r=0.759,P<0.05).结论 脑胶质瘤的~(18)F-FDG摄取水平与HIF-1α表达及MVD之间存在良好相关性,可在术前一定程度上间接评估肿瘤的乏氧状态及血管生成情况,有助于全面评估病变的生物学特征及预后.
目的 探討人腦膠質瘤~(18)F-脫氧葡萄糖(FDG)攝取水平與乏氧誘導因子-1α(HIF-1α)錶達及微血管密度(MVD)之間的相關性.方法 對41例腦膠質瘤(其中高級彆腫瘤23例,低級彆腫瘤18例)患者術前行~(18)F-FDG PET檢查,計算腫瘤與對側正常腦白質的最大標準攝取值(SUV_(max))比值(T/WM).腫瘤標本採用免疫組織化學染色,觀察HIF-1α錶達及定量研究腫瘤MVD,評價T/WM與HIF-1α錶達及MVD的相關性.用SPSS 11.5軟件進行t檢驗、單因素方差分析及Spearman相關分析、Wilcoxon秩和檢驗.結果 (1)高、低級彆腫瘤的T/WM、HIF-1α暘性錶達率及MVD分彆為3.39 ±1.43,95.7%,44.13±16.1和1.46±0.55,55.6%,18.83±7.07,2組間T/WM、HIF-1α錶達及MVD差異均有統計學意義(t=-5.921,z=-3.938,t=-6.745,P均<0.05).(2)所有病例中HIF-1α彊錶達8例,中度錶達9例,弱錶達15例,陰性錶達9例.T/WM及MVD均隨HIF1α錶達水平升高而增加,組間差異有統計學意義(F=7.41,P<0.05).(3)Spearman相關分析錶明,41例膠質瘤的T/WM與MVD呈明顯正相關(r=0.759,P<0.05).結論 腦膠質瘤的~(18)F-FDG攝取水平與HIF-1α錶達及MVD之間存在良好相關性,可在術前一定程度上間接評估腫瘤的乏氧狀態及血管生成情況,有助于全麵評估病變的生物學特徵及預後.
목적 탐토인뇌효질류~(18)F-탈양포도당(FDG)섭취수평여핍양유도인자-1α(HIF-1α)표체급미혈관밀도(MVD)지간적상관성.방법 대41례뇌효질류(기중고급별종류23례,저급별종류18례)환자술전행~(18)F-FDG PET검사,계산종류여대측정상뇌백질적최대표준섭취치(SUV_(max))비치(T/WM).종류표본채용면역조직화학염색,관찰HIF-1α표체급정량연구종류MVD,평개T/WM여HIF-1α표체급MVD적상관성.용SPSS 11.5연건진행t검험、단인소방차분석급Spearman상관분석、Wilcoxon질화검험.결과 (1)고、저급별종류적T/WM、HIF-1α양성표체솔급MVD분별위3.39 ±1.43,95.7%,44.13±16.1화1.46±0.55,55.6%,18.83±7.07,2조간T/WM、HIF-1α표체급MVD차이균유통계학의의(t=-5.921,z=-3.938,t=-6.745,P균<0.05).(2)소유병례중HIF-1α강표체8례,중도표체9례,약표체15례,음성표체9례.T/WM급MVD균수HIF1α표체수평승고이증가,조간차이유통계학의의(F=7.41,P<0.05).(3)Spearman상관분석표명,41례효질류적T/WM여MVD정명현정상관(r=0.759,P<0.05).결론 뇌효질류적~(18)F-FDG섭취수평여HIF-1α표체급MVD지간존재량호상관성,가재술전일정정도상간접평고종류적핍양상태급혈관생성정황,유조우전면평고병변적생물학특정급예후.
Objective To investigate the correlation between ~(18)F-fluorodeoxyglucose (FDG) uptake and hypoxia inducible factor1α (HIF-1α) level,microvessel density (MVD) in human gliomas.Methods ~(18)F-FDG PET scan was performed preoperatively in 41 patients with gliomas (including 23 highgrade and 18 low-grade tumors).The ratios of maximum standardized uptake value(SUV_(max))between tumor (T)and contralateral white matter (WM) were calculated (T/WM).Immunohistochemical stain methods were used to evaluate the level of HIF-1α and measure the MVD in tumors.Correlation analysis between SUV_(max) of T/WM and HIF-1α level,MVD wag performed.The t-test,one-way ANOVA test,Spearman rank correlation and Wilcoxon signed-rank test were calculated using SPSS 11.5 software.Results (1)The SUV_(max) of T/WM,HIF-1α level and MVD in high-grade and low-grade tumors groups were 3.39±1.43,95.7% and 44.13±16.1 vs 1.46±0.55.55.6% and 18.83±7.07,respectively.The difierences of SUV_(max) of T/WM,HIF-1α level and MVD between two groups were statistically significant (t=-5.921,z=-3.938,t=-6.745,all P<0.05).(2)Among 41 gliomas,the strong positive expression of HIF-1α was observed in 8,mederate in 9,weak in 15 and negative expression was found in 9,SUV_(max) of T/WM and MVD increased with increasing HIF-1α level.The differences of SUV_(max) of T/WM and MVD among 4 different groups were statistically significant (F=7.41,P<0.05).(3) The MVD of all gliomas was ranged from 9.76 to 94.52,which correlated with SUV_(max) of T/WM(r=0.759,P<0.05).Conclusions The SUV_(max) of T/WM correlates with HIF-1α level and MVD in gliomas.Therefore,~(18)F-FDG PET provides preoperatively a noninvasive assessment of hypoxia or angiogenesis in human glionma.